(Q40159695)

18 September 2017

1 reference

title

Are there anticompulsive or antiphobic drugs? Review of the evidence (English)

1 reference

18 September 2017

Are there Anticompulsive or Antiphobic Drugs? Review of the Evidence (English)

1 reference

https://api.crossref.org/works/10.1192/BJP.143.4.338

6 October 2023

author name string

I. Marks

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6354342

6 October 2023

language of work or name

English

0 references

publication date

1 October 1983

1 reference

full work available at URL

18 September 2017

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0007125000200470

1 reference

https://api.crossref.org/works/10.1192/BJP.143.4.338

British Journal of Psychiatry

6 October 2023

published in

1 reference

18 September 2017

143

1 reference

18 September 2017

338-347

1 reference

Current concepts in psychiatry. Panic attacks and phobias

18 September 2017

2

1 reference

https://api.crossref.org/works/10.1192/BJP.143.4.338

A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety

6 October 2023

3

1 reference

https://api.crossref.org/works/10.1192/BJP.143.4.338

The managment of severe agoraphobia: a comparison of iproniazid and systematic desensitization

6 October 2023

4

1 reference

https://api.crossref.org/works/10.1192/BJP.143.4.338

Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial

6 October 2023

5

1 reference

https://api.crossref.org/works/10.1192/BJP.143.4.338

Does tryptophan potentiate clomipramine in the treatment of agoraphobic and social phobic patients?

6 October 2023

6

1 reference

https://api.crossref.org/works/10.1192/BJP.143.4.338

School phobia: a therapeutic trial with clomipramine and short-term outcome

6 October 2023

7

1 reference

https://api.crossref.org/works/10.1192/BJP.143.4.338

Clomipramine and exposure for chronic obsessive-compulsive rituals: III. Two year follow-up and further findings.

6 October 2023

10

1 reference

https://api.crossref.org/works/10.1192/BJP.143.4.338

Imipramine and Brief Therapist-Aided Exposure in Agoraphobics Having Self-exposure Homework

6 October 2023

12

1 reference

https://api.crossref.org/works/10.1192/BJP.143.4.338

A Clinical Trial of Phenelzine in Anxiety Depressive and Phobic Neuroses

6 October 2023

14

1 reference

https://api.crossref.org/works/10.1192/BJP.143.4.338

DELINEATION OF TWO DRUG-RESPONSIVE ANXIETY SYNDROMES

6 October 2023

15

1 reference

https://api.crossref.org/works/10.1192/BJP.143.4.338

Treatment of Agoraphobia With Group Exposure In Vivo and Imipramine

6 October 2023

16

1 reference

https://api.crossref.org/works/10.1192/BJP.143.4.338

Phenelzine and exposure in the treatment of phobias

6 October 2023

19

1 reference

https://api.crossref.org/works/10.1192/BJP.143.4.338

Behavior Therapy, Supportive Psychotherapy, Imipramine, and Phobias

6 October 2023

20

1 reference

https://api.crossref.org/works/10.1192/BJP.143.4.338

Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.

6 October 2023

21

1 reference

https://api.crossref.org/works/10.1192/BJP.143.4.338

Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline

6 October 2023

27

1 reference

https://api.crossref.org/works/10.1192/BJP.143.4.338

Clomipramine and exposure for obsessive-compulsive rituals: i

6 October 2023

28

1 reference

https://api.crossref.org/works/10.1192/BJP.143.4.338

Brief standard self-rating for phobic patients

6 October 2023

30

1 reference

https://api.crossref.org/works/10.1192/BJP.143.4.338

Symptomatic Treatment of Agoraphobia and Social Phobias: A Follow-up Study

6 October 2023

32

1 reference

https://api.crossref.org/works/10.1192/BJP.143.4.338

6 October 2023

Identifiers

1 reference

18 September 2017

1 reference